9 research outputs found

    miRNAs in platelets have a unique expression profile in SCD patients based on Doppler-estimated TRV and HU treatment.

    No full text
    <p>(A) The heatmap represents 23 statistically significant (<i>p</i>-value<0.1, FC>2) differentially expressed miRNAs between subjects with (N = 18) and without (N = 8) elevated TRV (>2.5 m/sec). (B) The heatmap represents 10 statistically significant (<i>p</i>-value<0.1, FC>2) differentially expressed miRNAs between the subjects on (N = 14) and off HU (N = 12). Every row represents a gene and every column is a patient. Upregulated miRNAs are shown in yellow color, downregulated miRNAs are shown in purple and no difference is grey. The names of the miRNAs are displayed to the right of heatmap.</p

    MiRNAs in platelets of SCD patients are differentially expressed.

    No full text
    <p>(<b>A</b>) Characterization of purified platelet preparation by flow cytometry. (<b>B</b>) Bioanalyzer assessment of RNA samples from purified platelet preps showing good quality with RIN of 7.8. (<b>C</b>) Venn diagram comparing differentially expressed miRNAs from two independent study cohorts. Comparison of 259 differentially expressed miRNAs from NHLBI samples and 67 differentially expressed miRNAs from UPMC samples. In total, there are 40 miRNAs overlapping between the two cohorts. (<b>D</b>) The heatmap depicts the 40 statistically significant (<i>p</i>-value<0.05, FC>2) differentially expressed miRNAs between SCD and controls that were common between the two cohorts. Columns represent individual samples and each represents a miRNA. Upregulated miRNAs expression levels are shown in progressively brighter shades of yellow, depending on the fold difference. Downregulated miRNAs are shown in progressively brighter shades of purple. No difference is represented as grey. The names of the miRNAs are displayed to the right of the heatmap.</p

    miR-1225-3p regulates gene expression after transfection in MEG-01 cells.

    No full text
    <p>(<b>A</b>) Expression of the flourescent marker pmaxGFP plasmid as determined by flow cytometry demonstrates 76% GFP expressing cells out of the viable cell population. (<b>B</b>) qRT-PCR assay confirms overexpression of miR-1225-3p in MEG-01 cells (n = 5) vs scrambled (scr) (n = 5). (<b>C</b>) MT1X, PTPN6, IFI6, FCER1G and RAP2A are significantly downregulated in MEG-01 transfected cells as validated by qRT-PCR. (<b>D</b>) Schematic representation of overlap in differentially expressed genes between miR-1225-3p transfected MEG-01 cells and platelets from SCD patients. The numbers in the circles denote the differentially expressed genes with the leftmost figure representing genes using a FDR of 5% and the rightmost figure after applying a stringent statistical filter of FC>2. Further overlap with ComiR predicted target list of the 40 differentially expressed miRNAs resulted in a list of 7 genes potentially regulated by miR-1225-3p. (<b>E</b>) Out of the 7 genes, PLAGL2 and PBXIP1 genes are significantly downregulated and PHF20L1 is significantly upregulated in miR-1225-3p transfected cells vs scrambled. In the qRT-PCR figures (B, C and D), for each gene, the blue bar represents the cells transfected with scrambled RNA (n = 5) and the red bar represents the miR-1225-3p transfected cells (n = 5). Y-axis shows fold change of miR-1225-3p in transfected cells with the expression level in scrambled set to 1. Error bars are based on standard deviation. *denotes p-value<0.05.</p
    corecore